| Literature DB >> 23413839 |
Anna Biehl1, Ragnhild Hovengen, Haakon E Meyer, Jøran Hjelmesaeth, Jørgen Meisfjord, Else-Karin Grøholt, Mathieu Roelants, Bjørn Heine Strand.
Abstract
BACKGROUND: The basis for this study is the fact that instrument error increases the variance of the distribution of body mass index (BMI). Combined with a defined cut-off value this may impact upon the estimated proportion of overweight and obesity. It is important to ensure high quality surveillance data in order to follow trends of estimated prevalence of overweight and obesity. The purpose of the study was to assess the impact of instrument error, due to uncalibrated scales and stadiometers, on prevalence estimates of overweight and obesity.Entities:
Mesh:
Year: 2013 PMID: 23413839 PMCID: PMC3606378 DOI: 10.1186/1471-2458-13-146
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Figure 1Two hypothetical normal distributions of BMI with equal means but different variances; increased variance gives a lower and broader shape compared to a distribution with less variance. Vertical line indicates cut-off value (BMI ≥ 25 kg/m2). The dark shaded area corresponds to the prevalence of overweight and obesity for the distribution with less variance, and the light shaded area corresponds to additional prevalence due to increased variance.
Figure 2Procedure to determine correction values in the NCG-study. As part of the procedure to determine correction values in the NCG-study, the value of the stadiometer at each school (left) that corresponded to 120.0 cm of the reference length (right) was recorded. In practice, the folding rule was blacked out above and below 120 cm to avoid misunderstanding.
An overview of the two models presenting the coefficient of variation (CV%), mean and SD of instrument error and the corresponding estimated prevalence of overweight and obesity (BMI ≥ 25 kg/m) as mean, SD and the range (minimum-maximum values)
| | |||||||
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 1000 | 16.4 | 0 (16.4 – 16.4) |
| 0.5 | 0 | 0.15 | 0 | 0.66 | 1000 | 16.5 | 0.17 (15.9 – 17.1) |
| 1.0 | 0 | 0.29 | 0 | 1.32 | 1000 | 16.7 | 0.24 (16.0 – 17.5) |
| 1.5 | 0 | 0.44 | 0 | 1.98 | 1000 | 17.2 | 0.28 (16.3 – 18.0) |
| 2.0 | 0 | 0.58 | 0 | 2.64 | 1000 | 17.8 | 0.35 (16.7 – 19.2) |
| 2.5 | 0 | 0.73 | 0 | 3.30 | 1000 | 18.6 | 0.39 (17.2 – 19.6) |
| 3.0 | 0 | 0.87 | 0 | 3.96 | 1000 | 19.5 | 0.41 (18.1 – 20.7) |
| 3.5 | 0 | 1.02 | 0 | 4.62 | 1000 | 20.5 | 0.46 (19.1 – 22.1) |
| 4.0 | 0 | 1.16 | 0 | 5.28 | 1000 | 21.6 | 0.51 (19.5 – 23.2) |
| 2.1*/0.9** | 0 | 0.64 | 0 | 1.11 | 1000 | 16.9 | 0.25 (15.8 – 17.7) |
* CV of instrument error (%) of scales from the NCG-study.
**CV of instrument error (%) of stadiometers from the NCG-study.
Figure 3The mean estimated prevalence (%) of overweight and obesity (BMI ≥ 25 kg/m) in relation to the coefficient of variation (CV) of instrument error (%).